Skeletal Manifestations of Primary Hyperparathyroidism: A Series of Four Cases

Authors

  •   Shradha Srinivas Endocrine Surgery, Madras Medical College, Chennai – 600003, Tamil Nadu, India
  •   M.P Kumaran Endocrine Surgery, Madras Medical College, Chennai – 600003, Tamil Nadu, India
  •   M.S Senthilkumar Endocrine Surgery, Madras Medical College, Chennai – 600003, Tamil Nadu, India
  •   Dhalapathy Sadacharan Endocrine Surgery, Madras Medical College, Chennai – 600003, Tamil Nadu, India

DOI:

https://doi.org/10.65129/surgical.v1i3.86

Keywords:

Brown Tumour, Osteitis Fibrosacystica, Primary Hyperparathyroidism

Abstract

Primary Hyperparathyroidism (PHPT) has undergone a marked epidemiological shift worldwide, with Western countries reporting predominantly asymptomatic, screening-detected disease, whereas India continues to see a substantial burden of symptomatic PHPT. This case series describes four patients presenting with advanced skeletal manifestations of PHPT, highlighting diagnostic challenges, biochemical severity, and surgical outcomes. All patients presented with severe skeletal disease, including pathological fractures, brown tumours, and marked osteoporosis. Mean serum calcium and PTH of the cases were 13.7±1.5 mg/dL (12.3-15.1mg/dl) and 1960±929 pg/mL (870-2956 pg/ml) respectively. Diagnostic delay averaged 11.8 months, as all patients initially underwent extensive orthopaedic or oncologic evaluation. All four underwent parathyroidectomy for solitary adenomas and achieved complete biochemical cure. Hungry Bone Syndrome (HBS) occurred in all cases, requiring intravenous calcium. At one year, all patients demonstrated substantial clinical improvement, normalization of calcium and PTH, marked reduction in alkaline phosphatase, and significant gains in bone mineral density. Despite global declines in symptomatic PHPT, advanced skeletal disease persists in India, often compounded by vitamin D deficiency and diagnostic delay. Parathyroidectomy remains highly effective, producing excellent biochemical cure and dramatic skeletal recovery even in severe disease. Early calcium and PTH testing in patients with lytic lesions or unexplained fractures is essential for timely diagnosis.

Downloads

Download data is not yet available.

Downloads

Published

2025-06-25

How to Cite

Srinivas, S., Kumaran, M., Senthilkumar, M., & Sadacharan, D. (2025). Skeletal Manifestations of Primary Hyperparathyroidism: A Series of Four Cases. Journal of Surgery and Surgical Specialities, 1(3), 81–85. https://doi.org/10.65129/surgical.v1i3.86

Issue

Section

Case Series

References

1. Bhadada SK, Arya AK, Mukhopadhyay S, Khadgawat R, Sukumar S, Lodha S, et al. Primary hyperparathyroidism: insights from the Indian PHPT registry. J Bone Miner Metab. 2018; 36(2):238-45. https://doi.org/10.1007/s00774017-0833-8 PMID: 28364324.

2. Kamboj P, Dwivedi S, Toteja GS. Prevalence of hypovitaminosis D in India and way forward. Indian J Med Res. 2018; 148(5):548-56. https://doi.org/10.4103/ijmr.IJMR_1807_18 PMID: 30666982 PMCID: PMC6366270.

3. Jha S, Jayaraman M, Jha A, Jha R, Modi K, Kelwadee J. Primary hyperparathyroidism: a changing scenario in India. Indian J Endocrinol Metab. 2016; 20(1):80. https:// doi.org/10.4103/2230-8210.172237 PMID: 26904473 PMCID: PMC4743389.

4. Sadacharan D, Mathews MZ, Sathya A, Gopal S, Chandrasekaran S, Murthy S, et al. Primary hyperparathyroidism: clinical, biochemical, and radiopathological profiles of 804 patients- a retrospective study from South India. Indian J Endocrinol Metab. 2025; 29(1):6976. https://doi.org/10.4103/ijem.ijem_468_24 PMID: 40181859 PMCID: PMC11964361.

5. Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab. 2014; 99(10):3580-94. https://doi.org/10.1210/ jc.2014-1415 PMID: 25162667 PMCID: PMC5393491.

6. Bhansali A, Masoodi SR, Reddy KS, Behera A, Das Radotra B, Mittal BR, et al. Primary hyperparathyroidism in North India: a description of 52 cases. Ann Saudi Med. 2005; 25(1):29-35. https://doi.org/10.5144/0256-4947.2005.29 PMID: 15822491 PMCID: PMC6150565.

7. Mallikarjuna V, Mathew V, Ayyar V, Bantwal G, Ganesh V, George B, et al. Five-year retrospective study on primary hyperparathyroidism in South India: emerging roles of minimally invasive parathyroidectomy and preoperative localization with methionine PET-CT scan. Indian J Endocrinol Metab. 2018; 22(3):355. https://doi.org/10.4103/ijem.IJEM_445_16 PMID: 30090727 PMCID: PMC6063170.

8. Arya AK, Kumari P, Bhadada SK, Agrawal K, Singh P, Mukherjee S, et al. Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry. J Bone Miner Metab. 2021; 39(2):2539. https://doi.org/10.1007/s00774-020-01142-w PMID: 32894354.

9. Shah VN, Bhadada S, Bhansali A, Behera A, Mittal BR. Changes in clinical and biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Indian J Med Res. 2014; 139(5):694-9.

10. Misgar RA, Dar PM, Masoodi SR, Ahmad M, Wani KA, Wani AI, et al. Clinical and laboratory profile of primary hyperparathyroidism in Kashmir Valley: a single-center experience. Indian J Endocrinol Metab. 2016; 20(5):696. https://doi.org/10.4103/2230-8210.190560 PMID: 27730083 PMCID: PMC5040053.

11. Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018; 391(10116):168-78.

https://doi.org/10.1016/S0140-6736(17)31430-7 PMID: 28923463.

12. Udelsman R, Åkerström G, Biagini C, Duh QY, Miccoli P, Niederle B, et al. Surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab. 2014; 99(10):3595-606. https://doi.org/10.1210/jc.2014-2000 PMID: 25162669.

13. Souberbielle JC, Bienaimé F, Cavalier E, Cormier C. Vitamin D and Primary Hyperparathyroidism (PHPT). Ann Endocrinol (Paris). 2012; 73(3):165-9. https://doi.org/10.1016/j.ando.2012.04.008 PMID: 22677209.

14. Lorenz FJ, Beauchamp-Perez F, Manni A, Chung T, Goldenberg D, Goyal N. Analysis of time to diagnosis and outcomes among adults with primary hyperparathyroidism. JAMA Netw Open. 2022; 5(12):e2248332. https://doi.org/10.1001/jamanetworkopen.2022.48332 PMID: 36574247 PMCID: PMC9857508.

15. Witteveen JE, van Thiel S, Romijn JA, Hamdy NA. Hungry bone syndrome: still a challenge in postoperative management of primary hyperparathyroidism—a systematic review. Eur J Endocrinol. 2013; 168(3):R45-53.https://doi.org/10.1530/EJE-12-0528 PMID: 23152439.

16. Sharma J, Itum DS, Moss L, Chun-Li C, Weber C. Predictors of bone mineral density improvement after

parathyroidectomy for primary hyperparathyroidism. World J Surg. 2014; 38(6):1268-73. https://doi.org/10.1007/s00268-014-2555-6 PMID: 24744114.

17. Lu S, Gong M, Zha Y, Cui A, Chen C, Yang H, et al. Changes in bone mineral density after parathyroidectomy in patients with moderate to severe primary hyperparathyroidism. J Int Med Res. 2020; 48(10). https://doi.org/10.1177/0300060520964698 PMID: 33135515 PMCID: PMC7780563.eISSN: